New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Using mathematical modeling and dynamic biomarkers to characterize metastatic disease during adaptive therapy

Using mathematical modeling and dynamic biomarkers to characterize metastatic disease during adaptive therapy

byH. Lee Moffitt Cancer Center & Research InstituteMathematical model overview and design. A, Simulated treatment trajectory. During the seeding/growth phase, metastases are seeded and grown
Technology & AI January 04,2024
Using mathematical modeling and dynamic biomarkers to characterize metastatic disease during adaptive therapy

Using mathematical modeling and dynamic biomarkers to characterize metastatic disease during adaptive therapy

byH. Lee Moffitt Cancer Center & Research InstituteMathematical model overview and design. A, Simulated treatment trajectory. During the seeding/growth phase, metastases are seeded and grown
Technology & AI January 04,2024
Method that uses combination of immune cells could provide clearer prognoses

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-
Oncology January 04,2024
Method that uses combination of immune cells could provide clearer prognoses

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-
Oncology January 04,2024
AI model using daily step counts predicts unplanned hospitalizations during cancer therapy

AI model using daily step counts predicts unplanned hospitalizations during cancer therapy

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainAn artificial intelligence (AI) model developed by researchers can predict the likelihood that a patient may have an unp
Technology & AI January 04,2024
AI model using daily step counts predicts unplanned hospitalizations during cancer therapy

AI model using daily step counts predicts unplanned hospitalizations during cancer therapy

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainAn artificial intelligence (AI) model developed by researchers can predict the likelihood that a patient may have an unp
Technology & AI January 04,2024
Using machine learning to identify undiagnosable cancers

Using machine learning to identify undiagnosable cancers

by Bendta Schroeder,Massachusetts Institute of Technology“Machine learning tools like this one could empower oncologists to choose more effective treatments and give more guidance to their patie
Technology & AI January 04,2024
Using machine learning to identify undiagnosable cancers

Using machine learning to identify undiagnosable cancers

by Bendta Schroeder,Massachusetts Institute of Technology“Machine learning tools like this one could empower oncologists to choose more effective treatments and give more guidance to their patie
Technology & AI January 04,2024
Using SPEDOX-6 to provide targeted cancer treatment and protect heart cells

Using SPEDOX-6 to provide targeted cancer treatment and protect heart cells

by International Society for Stem Cell ResearchSPEDOX-6 causes less damage to heart cells than dox. Left: stem cell derived heart cells treated with dox. Right: stem cell derived heart cells treated w
Oncology January 04,2024
Using SPEDOX-6 to provide targeted cancer treatment and protect heart cells

Using SPEDOX-6 to provide targeted cancer treatment and protect heart cells

by International Society for Stem Cell ResearchSPEDOX-6 causes less damage to heart cells than dox. Left: stem cell derived heart cells treated with dox. Right: stem cell derived heart cells treated w
Oncology January 04,2024
Genetically engineered cell therapies with mRNA lipid nanoparticles for transferrable platelets

Genetically engineered cell therapies with mRNA lipid nanoparticles for transferrable platelets

by Thamarasee Jeewandara , Phys.orgPlatelets transfected with mRNA using LNP can express exogenous protein. (A) Schematic describing the transfection of platelets using mRNA-LNP. (B) NanoLuc expressio
Breakthroughs January 04,2024
Genetically engineered cell therapies with mRNA lipid nanoparticles for transferrable platelets

Genetically engineered cell therapies with mRNA lipid nanoparticles for transferrable platelets

by Thamarasee Jeewandara , Phys.orgPlatelets transfected with mRNA using LNP can express exogenous protein. (A) Schematic describing the transfection of platelets using mRNA-LNP. (B) NanoLuc expressio
Breakthroughs January 04,2024
Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have formulated a tuneable, nanoengineered bioink for tumor modeling which contai
Oncology January 04,2024
Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have formulated a tuneable, nanoengineered bioink for tumor modeling which contai
Oncology January 04,2024
Using the HALP score for prognostic ability in cancers: A literature review

Using the HALP score for prognostic ability in cancers: A literature review

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new review paper titled "What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP's p
Oncology January 04,2024
Using the HALP score for prognostic ability in cancers: A literature review

Using the HALP score for prognostic ability in cancers: A literature review

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new review paper titled "What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP's p
Oncology January 04,2024
The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

byBrigham and Women's HospitalA double stranded DNA fragment. Credit: Vcpmartin/Wikimedia/ CC BY-SA 4.0Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over th
Oncology January 04,2024
The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

byBrigham and Women's HospitalA double stranded DNA fragment. Credit: Vcpmartin/Wikimedia/ CC BY-SA 4.0Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over th
Oncology January 04,2024
Making glioblastoma more vulnerable to treatment

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o
Neurology January 04,2024
Making glioblastoma more vulnerable to treatment

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o
Neurology January 04,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com